Cargando…
Cholesterylbutyrate Solid Lipid Nanoparticles as a Butyric Acid Prodrug
Cholesterylbutyrate (Chol-but) was chosen as a prodrug of butyric acid. Butyrate is not often used in vivo because its half-life is very short and therefore too large amounts of the drug would be necessary for its efficacy. In the last few years butyric acid's anti-inflammatory properties and i...
Autores principales: | Brioschi, Andrea, Zara, Gian Paolo, Calderoni, Sara, Gasco, Maria Rosa, Mauro, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245427/ https://www.ncbi.nlm.nih.gov/pubmed/18305415 http://dx.doi.org/10.3390/molecules13020230 |
Ejemplares similares
-
Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
por: Rephaeli, A, et al.
Publicado: (2007) -
Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018) -
Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model
por: Dianzani, Chiara, et al.
Publicado: (2017) -
Improving the Oral Bioavailability of an Anti-Glioma Prodrug CAT3 Using Novel Solid Lipid Nanoparticles Containing Oleic Acid-CAT3 Conjugates
por: Wang, Hongliang, et al.
Publicado: (2020) -
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
por: Curley, Paul, et al.
Publicado: (2023)